Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma : a cytogenetic subgroup analysis of POLLUX
-
Kaufman, J. L. (Winship Cancer Institute. Emory University)
;
Dimopoulos, Meletios (The National and Kapodistrian University of Athens) ;
White, D. (Dalhousie University and Queen Elizabeth II Health Sciences Centre) ;
Benboubker, L. (Service d'Hématologie et Thérapie Cellulaire. Hôpital Bretonneau. Centre Hospitalier Régional Universitaire) ;
Cook, G. (St James's Institute of Oncology. Leeds Teaching Hospitals National Health Service Trust and University of Leeds) ;
Leiba, M. (Assuta Ashdod University Hospital. Faculty of Health Science Ben-Gurion University of the Negev) ;
Morton, J. (Icon Cancer Care) ;
Joy Ho, P. (Institute of Haematology. Royal Prince Alfred Hospital) ;
Kim, K. (Department of Medicine. Samsung Medical Center. Sungkyunkwan University School of Medicine) ;
Takezako, N. (Department of Hematology. National Hospital Organization Disaster Medical Center of Japan) ;
Moreau, Philippe (Hematology. University Hospital Hôtel-Dieu) ;
Sutherland, H. J. (Leukemia/Bone Marrow Transplant Program. University of British Columbia) ;
Magen, H. (Department of Hematology Chaim Sheba Medical Center. Ramat-Gan. Sackler Faculty of Medicine. Tel Aviv University) ;
Iida, S. (Department of Hematology and Oncology. Nagoya City University Graduate School of Medical Sciences) ;
Kim, J. S. (Yonsei University College of Medicine. Severance Hospital) ;
Miles Prince, H. (Cabrini Hospital. Epworth HealthCare and Sir Peter MacCallum Department of Oncology. University of Melbourne) ;
Cochrane, T. (Gold Coast University Hospital and Griffiths University) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Bahlis, N. J. (University of Calgary. Arnie Charbonneau Cancer Institute) ;
Chari, Ajai (Icahn School of Medicine at Mount Sinai) ;
O'Rourke, L. (Janssen Research & Development) ;
Trivedi, S. (Janssen Research & Development) ;
Casneuf, T. (Janssen Research & Development) ;
Krevvata, M. (Janssen Research & Development) ;
Ukropec, J. (Janssen Global Medical Affairs) ;
Kobos, R. (Janssen Research & Development) ;
Avet-Loiseau, Hervé (Unite de Genomique du Myelome. IUC-Oncopole) ;
Usmani, S. Z. (Levine Cancer Institute/Atrium Health) ;
San-Miguel, J. (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
